News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Celgene Corporation (CELG) Reports First Quarter 2013 Operating and Financial Results


4/25/2013 9:01:51 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Celgene Corporation (NASDAQ: CELG) reported net product sales of $1,429 million for the first quarter of 2013, a 15 percent increase from the same period in 2012. Adjusted net income for the first quarter of 2013 increased 22 percent to $592 million compared to $484 million in the first quarter of 2012. First quarter total revenue was $1,465 million compared to $1,273 million in first quarter of 2012. For the same period, adjusted diluted earnings per share increased 27 percent to $1.37 from $1.08.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES